CAS NO: | 1263131-92-5 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | MRT-83 is a potent antagonist ofSmo, with anIC50in the nanomolar range. MRT-83 also blocksHedgehog(Hh) signaling. | ||||||||||||||||
IC50& Target | Smo[1]. | ||||||||||||||||
体外研究 (In Vitro) | MRT-83 displays full antagonist properties with an IC50(~3 nM) for inhibiting ShhN (3 nM)-induced proliferation of rat GCPs. MRT-83 also blocks SAG (0.01 μM)-induced proliferation of GCPs (IC50~6 nM). MRT-83 blocks BC binding to HEK-hSmo cells in a dose-dependent manner with an IC50of 4.6 nM. MRT-83 abrogates BC binding to cells expressing mouse Smo with an IC50of 14 nM, which is in good correlation with its IC50in the Shh-light2 and alkaline phosphatase assays[1]. | ||||||||||||||||
体内研究 (In Vivo) | Animals treated with ShhN in the presence of MRT-83 are as healthy as those of the other groups but up-regulation of Ptc transcription in the SVZ of these animals is no longer observed in agreement with a complete inhibition of ShhN-mediated effects (8.7±2.4 Ptc+cells/section, n=9) and is not different from vehicle-mediated effects. MRT-83 but not MRT-36 antagonizes the up-regulation of Ptc transcription induced by ShhN in vivo in the SVZ of the LV[1]. | ||||||||||||||||
分子量 | 538.59 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C31H30N4O5 | ||||||||||||||||
CAS 号 | 1263131-92-5 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 250 mg/mL(464.17 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|